Review Series

The present and future of measurable residual disease testing in acute myeloid leukemia

Division of Hematology/Department of Medicine, The Ohio State University - The James Comprehensive Cancer Center, Columbus, OH; Department of Biomedical Informatics, The Ohio State University, Columbus, OH
Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA; Division of Hematology/Department of Medicine, University of Washington, Seattle, WA; Department of Laboratory Medicine & Pathology, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA
Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
Vol. 107 No. 12 (2022): December, 2022